Fieldview Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40,764
Closed -$441K 670
2026
Q1
$441K Buy
+40,764
New +$349K 0.13% 285
2025
Q2
Sell
-82,861
Closed -$681K 484
2025
Q1
$681K Buy
82,861
+67,772
+449% +$569K 0.1% 245
2024
Q4
$125K Buy
+15,089
New +$121K 0.02% 402

Other funds holding PTEN

Fieldview Capital Management's PTEN Position: Q2 2026 in Review

Fieldview Capital Management sold out of Patterson-UTI (PTEN) in Q2 2026, closing a stake of 40,764 shares — an estimated $441K sold.

Fieldview Capital Management first reported a position in PTEN in Q4 2024 and held it in 3 quarters. The position peaked at $681K in Q1 2025. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Fieldview Capital Management reported no remaining Patterson-UTI position as of Q2 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 40,764 Patterson-UTI shares in Q2 2026, an estimated $441K.
  • Fieldview Capital Management first reported a position in Patterson-UTI in Q4 2024 and held it in 3 quarters.
  • Fieldview Capital Management's Patterson-UTI position peaked at $681K in Q1 2025.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.